GlobeNewswire

Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
11/11/2026
The Company has more than doubled revenue from innovative medicines since launching Pivot to Growth in 2023, demonstrating sustained execution and the growing strength of its high-velocity biopharma model A live webcast [...]
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
11/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to [...]
BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026
11/11/2026
PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
11/11/2026
D-PLEX₁₀₀ NDA Under FDA Priority Review with PDUFA Goal Date of November 28, 2026; U.S. Commercial Launch Preparations Ongoing Expanding D-PLEX₁₀₀ Globally: MAA Submitted and Validated by the EMA and European [...]
Dyne Therapeutics to Participate in Upcoming Investor Conference
11/11/2026
WALTHAM, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Commercial Product Revenue from agenT-797, Randomized ARDS Trial Advancing, and ARPA-H Selection for Deployable Cell Therapies
11/11/2026
Patients with serious unmet medical need access agenT-797 through physician-requested named-patient access; generating the Company’s first product revenue Selected as the cell therapy for the Draper-led team in ARPA-H’s [...]
Boston Concierge Orthopedics Launches New Website Highlighting Shoulder and Knee Care
11/11/2026
Updated website introduces patients to specialized Orthopedic care, direct access to their surgeon, and treatment options across four Massachusetts locations BOSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Boston Concierge [...]
LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26
11/11/2026
LightSolver to present its Boeing corrosion-simulation work and join Birds of a Feather (BoF) session on analog computing at the supercomputing conference in Chicago Rehovot, Israel, Nov. 11, 2026 (GLOBE NEWSWIRE) -- [...]
BioAge Labs to Present at Upcoming Investor Conferences
11/11/2026
EMERYVILLE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic [...]
Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board
11/11/2026
Appointment brings leadership experience building and financing biopharma companies AUSTIN, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA), a biotechnology company focused on [...]
Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London
11/11/2026
LONDON and CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics (Beacon or the Company), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare [...]
Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026
11/11/2026
– Presentations include interim Phase 3 results in women, integrated outcomes from three Phase 3 dialysis access trials and long-term human explant data. – Podium presentation to provide an update on clinical results [...]
aTyr Pharma to Participate in Upcoming Investor Conferences
11/11/2026
SAN DIEGO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026
11/11/2026
BOSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- ImvivaBio, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced new research findings at the American College of [...]
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London
11/11/2026
EMERYVILLE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative [...]
CenTrak Launches Mobile Capability to Extend Staff Safety Beyond Hospital Walls
11/11/2026
Duress RT Mobile expands staff protection across indoor, outdoor and off-site environments with real-time location visibility through a singularly connected incident management system NEWTOWN, Pa., Nov. 11, 2026 (GLOBE [...]
Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London
11/11/2026
CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
11/11/2026
THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a [...]
Ultragenyx to Participate at Investor Conferences in London
11/11/2026
NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum